Table 1 Baseline patient characteristics
Parameters | Control group | Calcium 5 group | Calcium 10 group | P |
|---|---|---|---|---|
n | 26 | 26 | 26 | |
Age (years) | 55 (48 to 59) | 59 (53 to 62) | 57 (54 to 60) | 0.790 |
Male | 20 | 14 | 21 | 0.071 |
Height (cm) | 166.7 (159.6 to 173.7) | 162.8 (157.5 to 169.6) | 168.0 (158.5 to 171.6) | 0.201 |
Weight (kg) | 65.6 (63.2 to 67.9) | 64.2 (52.8 to 71.5) | 63.4 (55.0 to 69.5) | 0.431 |
BMI (kg/m2) | 24.1 (22.6 to 24.9) | 23.6 (21.4 to 25.4) | 23.3 (21.1 to 24.1) | 0.196 |
Preoperative serum calcium concentration (mg/dL) | 4.4 (4.3 to 4.7) | 4.5 (4.3 to 4.5) | 4.5 (4.3 to 4.6) | 0.964 |
Preoperative serum magnesium concentration (mg/dL) | 2.2 (2.1 to 2.2) | 2.1 (1.9 to 2.2) | 2.1 (2.0 to 2.1) | 0.052 |
Temperature at neostigmine administration (°C) | 35.9 (35.6 to 36.3) | 36.0 (35.5 to 36.2) | 36.0 (35.8 to 36.3) | 0.511 |
Total dose of rocuronium (mg) | 50 (50 to 60) | 50 (50 to 60) | 50 (50 to 60) | 0.810 |
Total dose of vecuronium (mg) | 6 (4 to 6) | 7 (6 to 8) | 7 (5 to 9) | 0.120 |
Duration of surgery (min) | 135 (120 to 155) | 138 (130 to 160) | 140 (125 to 175) | 0.909 |
Duration of anesthesia (min) | 195 (160 to 215) | 190 (180 to 215) | 185 (175 to 240) | 0.776 |